Therapeutic potential of endothelial progenitor cells for cardiovascular diseases

Lijing Jia, Masafumi Takahashi, Toru Yoshioka, Hajime Morimoto, Hirohiko Ise, Uichi Ikeda

Research output: Contribution to journalReview article

30 Citations (Scopus)

Abstract

In the past decade, researchers have defined committed stem or progenitor cells from various tissues, including bone marrow, peripheral blood, brain, liver and reproductive organs, in both adult animals and humans. Recently, endothelial progenitor cells (EPCs) were isolated from peripheral blood mononuclear cells and were shown to be incorporated into foci of neovascularization. This finding that circulating EPCs may home into sites of neovascularization and differentiate into mature endothelial cells in situ is consistent with the concept of 'vasculogenesis' and suggests that vasculogenesis and angiogenesis might constitute complementary mechanisms for postnatal neovascularization. Furthermore, experimental and clinical studies on ischemic cardiovascular diseases suggest a therapeutic potential for EPC transplantation. In this review, we summarize the biological features of EPCs and discuss their therapeutic potential for the treatment of cardiovascular diseases.

Original languageEnglish
Pages (from-to)59-65
Number of pages7
JournalCurrent Vascular Pharmacology
Volume4
Issue number1
DOIs
Publication statusPublished - Dec 1 2006
Externally publishedYes

Fingerprint

Cardiovascular Diseases
Stem Cells
Cell Transplantation
Therapeutics
Blood Cells
Endothelial Cells
Bone Marrow
Research Personnel
Endothelial Progenitor Cells
Liver
Brain

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Therapeutic potential of endothelial progenitor cells for cardiovascular diseases. / Jia, Lijing; Takahashi, Masafumi; Yoshioka, Toru; Morimoto, Hajime; Ise, Hirohiko; Ikeda, Uichi.

In: Current Vascular Pharmacology, Vol. 4, No. 1, 01.12.2006, p. 59-65.

Research output: Contribution to journalReview article

Jia, Lijing ; Takahashi, Masafumi ; Yoshioka, Toru ; Morimoto, Hajime ; Ise, Hirohiko ; Ikeda, Uichi. / Therapeutic potential of endothelial progenitor cells for cardiovascular diseases. In: Current Vascular Pharmacology. 2006 ; Vol. 4, No. 1. pp. 59-65.
@article{7c70c1b4ecac4b238919bb081cc100bd,
title = "Therapeutic potential of endothelial progenitor cells for cardiovascular diseases",
abstract = "In the past decade, researchers have defined committed stem or progenitor cells from various tissues, including bone marrow, peripheral blood, brain, liver and reproductive organs, in both adult animals and humans. Recently, endothelial progenitor cells (EPCs) were isolated from peripheral blood mononuclear cells and were shown to be incorporated into foci of neovascularization. This finding that circulating EPCs may home into sites of neovascularization and differentiate into mature endothelial cells in situ is consistent with the concept of 'vasculogenesis' and suggests that vasculogenesis and angiogenesis might constitute complementary mechanisms for postnatal neovascularization. Furthermore, experimental and clinical studies on ischemic cardiovascular diseases suggest a therapeutic potential for EPC transplantation. In this review, we summarize the biological features of EPCs and discuss their therapeutic potential for the treatment of cardiovascular diseases.",
author = "Lijing Jia and Masafumi Takahashi and Toru Yoshioka and Hajime Morimoto and Hirohiko Ise and Uichi Ikeda",
year = "2006",
month = "12",
day = "1",
doi = "10.2174/157016106775203063",
language = "English",
volume = "4",
pages = "59--65",
journal = "Current Vascular Pharmacology",
issn = "1570-1611",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Therapeutic potential of endothelial progenitor cells for cardiovascular diseases

AU - Jia, Lijing

AU - Takahashi, Masafumi

AU - Yoshioka, Toru

AU - Morimoto, Hajime

AU - Ise, Hirohiko

AU - Ikeda, Uichi

PY - 2006/12/1

Y1 - 2006/12/1

N2 - In the past decade, researchers have defined committed stem or progenitor cells from various tissues, including bone marrow, peripheral blood, brain, liver and reproductive organs, in both adult animals and humans. Recently, endothelial progenitor cells (EPCs) were isolated from peripheral blood mononuclear cells and were shown to be incorporated into foci of neovascularization. This finding that circulating EPCs may home into sites of neovascularization and differentiate into mature endothelial cells in situ is consistent with the concept of 'vasculogenesis' and suggests that vasculogenesis and angiogenesis might constitute complementary mechanisms for postnatal neovascularization. Furthermore, experimental and clinical studies on ischemic cardiovascular diseases suggest a therapeutic potential for EPC transplantation. In this review, we summarize the biological features of EPCs and discuss their therapeutic potential for the treatment of cardiovascular diseases.

AB - In the past decade, researchers have defined committed stem or progenitor cells from various tissues, including bone marrow, peripheral blood, brain, liver and reproductive organs, in both adult animals and humans. Recently, endothelial progenitor cells (EPCs) were isolated from peripheral blood mononuclear cells and were shown to be incorporated into foci of neovascularization. This finding that circulating EPCs may home into sites of neovascularization and differentiate into mature endothelial cells in situ is consistent with the concept of 'vasculogenesis' and suggests that vasculogenesis and angiogenesis might constitute complementary mechanisms for postnatal neovascularization. Furthermore, experimental and clinical studies on ischemic cardiovascular diseases suggest a therapeutic potential for EPC transplantation. In this review, we summarize the biological features of EPCs and discuss their therapeutic potential for the treatment of cardiovascular diseases.

UR - http://www.scopus.com/inward/record.url?scp=33644850228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644850228&partnerID=8YFLogxK

U2 - 10.2174/157016106775203063

DO - 10.2174/157016106775203063

M3 - Review article

C2 - 16472177

AN - SCOPUS:33644850228

VL - 4

SP - 59

EP - 65

JO - Current Vascular Pharmacology

JF - Current Vascular Pharmacology

SN - 1570-1611

IS - 1

ER -